Insiders · Profile

Ballantyne Charles Evan

Chief Financial Officer at AGENUS · Chief Financial Officer at Theriva Biologics. Filing since 22 May 2014. CIK 0001371742

Company
Date
Role
Action
Shares
Amount
Of holding
25 Sep 2015
Chief Financial Officer
Bought
10,000
$50.50K
opened
22 May 2014
Chief Financial Officer
Bought
10,000
$13.50K
opened
2 decisions on file.